QSAR on aryl-piperazine derivatives with activity on malaria

Chemometrics and Intelligent Laboratory Systems

Volumn 110, Issue 1, 2012, Pages 81-88

  Ibezim, Emmanuel ^a   Duchowicz, Pablo R ^a   Ortiz, Erlinda V ^b   Castro, Eduardo A ^a  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^b UNIVERSIDAD NACIONAL DE CATAMARCA   (Argentina)

Author keywords

Artemisinin; Aryl piperazines; Molecular descriptors; QSAR Theory; Replacement Method

Indexed keywords

ANTIMALARIAL AGENT; ARYLPIPERAZINE DERIVATIVE; CHLOROQUINE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CALCULATION; CHEMICAL MODIFICATION; DRUG POTENCY; DRUG STRUCTURE; IC 50; LINEAR REGRESSION ANALYSIS; MALARIA; MOLECULAR INTERACTION; PLASMODIUM FALCIPARUM; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL; VALIDATION PROCESS;

EID: 83655184806     PISSN: 01697439     EISSN: 18733239     Source Type: Journal    
DOI: 10.1016/j.chemolab.2011.10.002     Document Type: Article

References (42)

1. Malaria Facts. Centers for Disease Control and Prevention, 2011. http://www.cdc.gov/malaria/about/facts.html.
2. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. Nature 2005, 434:214.
3. Malaria: Disease Impacts and Long-Run Income Differences (PDF). Institute for the Study of Labor, 2007. http://ftp.iza.org/dp2997.pdf.
4. Molyneaux C.A., Krugliak M., Ginsburg H., Chibale K. Biochemical Pharmacology 2005, 71:61.
5. Willcox M.L., Bodeker G. BMJ 2004, 329:1156.
6. Yoshida S., Shimada Y., Kondoh D., Kouzuma Y., Ghosh A.K., Jacobs-Lorena M., Sinden R.E. PLoS Pathogens 2007, 3:1962.
7. [7] RTS,S vaccine protection rate.
8. Hansch C., Leo A. Exploring QSAR. Fundamentals and Applications in Chemistry and Biology 1995, American Chemical Society, Washington, D. C.
9. Milano Chemometrics and QSAR Research Group http://michem.disat.unimib.it/chm.
10. Karelson M. Molecular Descriptors in QSAR/QSPR 2000, Wiley-Interscience, New York.
11. Duchowicz P.R., Fernández M., Caballero J., Castro E.A., Fernández F.M. Bioorganic & Medicinal Chemistry 2006, 14:5876.
12. Duchowicz P.R., Vitale M.G., Castro E.A., Fernandez M., Caballero J. Bioorganic & Medicinal Chemistry 2007, 15:2680.
13. Duchowicz P.R., Talevi A., Bruno-Blanch L.E., Castro E.A. Bioorganic & Medicinal Chemistry 2008, 16:7944.
14. Goodarzi M., Duchowicz P.R., Wu C.H., Fernández F.M., Castro E.A. Journal of Chemical Information and Modeling 2009, 49:1475.
15. Vicente E., Duchowicz P.R., Castro E.A., Monge A. Journal of Molecular Graphics & Modelling 2009, 28:28.
16. Hyperchem 7 2007, (Hypercube, Inc.), Gainesville. http://www.hyper.com.
17. Todeschini R., Consonni V. Molecular Descriptors for Chemoinformatics 2009, Wiley-VCH, Weinheim.
18. Recon, Version 5.5. Rensselaer Polytechnic Institute, Troy, New York, USA http://www.drugmining.com.
19. Lavine B.K., Davidson C.E., Breneman C., Katt W. Journal of Chemical Information and Computer Sciences 2003, 43:1890.
20. Worachartcheewan A., Nantasenamat C., Naenna T., Isarankura-Na-Ayudhya C., Prachayasittikul V. European Journal of Medicinal Chemistry 2009, 44:1664.
21. Bader R.F.W. Atoms in Molecules - A Quantum Theory 1990, Clarendon Press, Oxford.
22. Breneman C.M., Weber L.W. The Application of Charge Density Research to Chemistry and Drug Design, Plenum, New York 1991, G.A. Jeffrey, J.F. Piniella (Eds.).
23. Duchowicz P.R., Castro E.A., Fernández F.M., González M.P. Chemical Physics Letters 2005, 412:376.
24. Mercader A.G., Duchowicz P.R., Fernández F.M., Castro E.A. Chemometrics and Intelligent Laborary Systems 2008, 92:138.
25. Duchowicz P.R., Goodarzi M., Ocsachoque M.A., Romanelli G.P., Ortiz E.V., Autino J.C., Bennardi D.O., Ruiz D., Castro E.A. Science of the Total Environment 2009, 408:277.
26. Multicollinearity.doc © 2002 Jeeshim and KUCC625. (2003-05-09).
27. Curto J.D., Pinto J.C. International Statistics Reviews 2007, 75:114.
28. Coral 1.4, http://www.insilico.eu/coral.
29. ACD/ChemSketch Freeware, version 12.01 2009, Advanced Chemistry Development, Inc., Toronto, ON, Canada. http://www.acdlabs.com.
30. Toropov A.A., Benfenati E. Current Drug Discovery Technology 2007, 4:77.
31. Toropov A.A., Benfenati E. Bioorganic & Medicinal Chemistry 2008, 26:4801.
32. Toropov A.A., Toropova A.P., Benfenati E. Chemical Biology & Drug Design 2009, 73:515.
33. Toropov A.A., Toropova A.P., Benfenati E., Leszczynska D., Leszczynski J. European Journal of Medicinal Chemistry 2010, 45:1387.
34. Wold S. L. Eriksson. Chemometrics Methods in Molecular Design 1995, 309-318. Weinheim, VCH. H. van de Waterbeemd (Ed.).
35. Hawkins D.M., Basak S.C., Mills D. Journal of Chemical Information and Modeling 2003, 43:579.
36. Golbraikh A., Tropsha A. Journal of Molecular Graphics and Modelling 2002, 20:269.
37. Draper N.R., Smith H. Applied Regression Analysis 1981, John Wiley & Sons, New York.
38. Matlab 5.0, The MathWorks, Inc., Natick, Massachusetts, USA, 2011. http://www.mathworks.com.
39. Bultinck P. Computational Medicinal Chemistry for Drug Discovery 2004, CRC Press, Boca Raton, FL.
40. Silverman B.D. Journal of Chemical Information and Modeling 2000, 40:1470.
41. Consonni V., Todeschini R., Pavan M., Gramatica P. Journal of Chemical Information and Modeling 2002, 42:693.
42. Schuur J., Selzer P., Gasteiger J. Journal of Chemical Information and Modeling 1996, 36:334.